Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver Disease

Sunny, Nishanth E., Parks, Elizabeth J., Browning, Jeffrey D., Burgess, Shawn C.·2011·Cell Metabolism

DOI 10.1016/j.cmet.2011.11.004

Cited by (683)

Items 101–200 of 683

Nonalcoholic fatty liver disease: Update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine
Mazen Noureddin, José María Mato, Shelly Chi-Loo Lu · 2015 · Experimental Biology and Medicine
Review article: drug‐induced liver injury in the context of nonalcoholic fatty liver disease – a physiopathological and clinical integrated view
Fernando Bessone, Melisa Dirchwolf, María Agustina Rodil, María Valeria Razori, Marcelo G. Roma · 2018 · Alimentary Pharmacology & Therapeutics
Mitochondrial oxidative function in NAFLD: Friend or foe?
Michaël Shum, Jennifer Ngo, Orian S. Shirihai, Marc Liesa · 2020 · Molecular Metabolism
Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease
Nishanth E. Sunny, Srilaxmi Kalavalapalli, Fernando Bril, Timothy J. Garrett, Manisha Nautiyal, Justin T. Mathew, Caroline M. Williams, Kenneth J. Cusi · 2015 · American Journal of Physiology-Endocrinology and Metabolism
Mitochondrial Dysfunction is a Key Pathway that Links Saturated Fat Intake to the Development and Progression of NAFLD
Ruth C. R. Meex, Ellen E. Blaak · 2020 · Molecular Nutrition & Food Research
Caloric restriction of db/db mice reverts hepatic steatosis and body weight with divergent hepatic metabolism
Kyung Eun Kim, Youngae Jung, Soonki Min, Miso Nam, Rok Won Heo, Byeong Tak Jeon, Dae Hyun Song, Chin‐ok Yi, Eun Ae Jeong, Hwajin Kim et al. · 2016 · Scientific Reports
Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease
Aigli‐Ioanna Legaki, Ioannis I. Moustakas, Michalina Sikorska, Grigorios Papadopoulos, Rallia-Iliana Velliou, Antonios Chatzigeorgiou · 2022 · Current Obesity Reports
The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD
Ting Hong, Yiyan Chen, Xiaoying Li, Yan Lü · 2021 · Oxidative Medicine and Cellular Longevity
HIV Treatment and Associated Mitochondrial Pathology
Kristian Gardner, Peter A. Hall, Patrick Francis Chinnery, Brendan A. I. Payne · 2013 · Toxicologic Pathology
NADPH and Glutathione Redox Link TCA Cycle Activity to Endoplasmic Reticulum Homeostasis
Erica R. Gansemer, Kyle S. McCommis, Michael R. Martino, Abdul Qaadir King-McAlpin, Matthew J. Potthoff, Brian N. Finck, Eric B. Taylor, D. Thomas Rutkowski · 2020 · iScience
Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease
Rebecca C. Schugar, Peter A. Crawford · 2012 · Current Opinion in Clinical Nutrition & Metabolic Care
Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load
Gambino, Roberto, Bugianesi, Elisabetta, Rosso, Chiara, Mezzabotta, Lavinia, Pinach, Silvia, Alemanno, Natalina, Saba, Francesca, Cassader, Maurizio · 2016 · International Journal of Molecular Sciences
Mitochondrial dysfunction and liver disease: role, relevance, and potential for therapeutic modulation
P. Middleton, N. Vergis · 2021 · Therapeutic Advances in Gastroenterology
Type 2 Diabetes Mellitus: Limitations of Conventional Therapies and Intervention with Nucleic Acid-Based Therapeutics
Ganesh Rajendra Kokil, Rakesh Naduvile Veedu, Grant A. Ramm, Johannes B. Prins, Harendra S. Parekh · 2015 · Chemical Reviews
Fatty liver as a consequence and cause of insulin resistance: Lessons from type 2 diabetic liver
Toshinari Takamura, Hirofumi Misu, Tsuguhito Ota, Shuichi Kaneko · 2012 · Endocrine Journal
Direct assessment of hepatic mitochondrial oxidative and anaplerotic fluxes in humans using dynamic 13C magnetic resonance spectroscopy
Douglas E. Befroy, Rachel J. Perry, Nimit Jain, Sylvie Dufour, Gary W. Cline, Jeff K. Trimmer, Julia M. Brosnan, Douglas L. Rothman, Kitt Falk Petersen, Gerald I. Shulman · 2013 · Nature Medicine
A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial
Saeed Chashmniam, Seyed Reza Mirhafez, Maryam Dehabeh, Mitra Hariri, Mohsen Azimi–Nezhad, B. Fatemeh Nobakht M. Gh · 2019 · European Journal of Clinical Nutrition
Fibroblast growth factor 21 reflects liver fat accumulation and dysregulation of signalling pathways in the liver of C57BL/6J mice
Fenni Rusli, Joris Deelen, Evi Andriyani, Mark V. Boekschoten, Carolien Lute, Erik B. van den Akker, Michael M. Müller, Marian Beekman, Wilma T. Steegenga · 2016 · Scientific Reports
Effects of exercise training on intrahepatic lipid content in humans
Brouwers, Bram, Hesselink, Matthijs K. C., Schrauwen, Patrick, Schrauwen-Hinderling, Vera B. · 2016 · Diabetologia
Non-Alcoholic Fatty Liver Disease and Nutritional Implications: Special Focus on Copper
Laura Antonucci, Cristiana Porcu, Gino Iannucci, Clara Balsano, Barbara Barbaro · 2017 · Nutrients
Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH
Leigh Goedeke, Gerald I. Shulman · 2021 · Molecular Metabolism
Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)
Santiago Iturbe-Rey, Cláudia Maccali, Marco A. Arrese, Patricia Aspichueta, Claudia Pinto Marques Souza de Oliveira, Rui Eduardo Castro, Ainhoa Lapitz, Laura Izquierdo‐Sánchez, Luís Bujanda, Maria Jesus Perugorria et al. · 2024 · Atherosclerosis
Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome
D. André d’Avignon, Patrycja Puchalska, Barış Erçal, YingJu Chang, Shannon E. Martin, Mark J. Graham, Gary J. Patti, Xianlin Han, Peter A. Crawford · 2018 · JCI Insight
Oxidative Stress in Non-Alcoholic Fatty Liver Disease
Carlo Smirne, Eleonora Croce, Davide Di Benedetto, Vincenzo Cantaluppi, Cristoforo Comi, Pier Paolo Sainaghi, Rosalba Minisini, Elena Grossini, Mario Pirisi · 2022 · Livers
Punicalagin attenuates palmitate‐induced lipotoxicity in HepG2 cells by activating the Keap1‐Nrf2 antioxidant defense system
Chunhong Yan, Wenyan Sun, Xun Wang, Jiangang Long, Xuebo Liu, Zhihui Feng, Jiankang Liu · 2016 · Molecular Nutrition & Food Research
The metabolic basis of nonalcoholic steatohepatitis
Manu V. Chakravarthy, Brent A. Neuschwander‐Tetri · 2020 · Endocrinology Diabetes & Metabolism
Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease
Raja Gopal Reddy Mooli, Sadeesh Kumar Ramakrishnan · 2022 · Frontiers in Physiology
In Vivo Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopy Reveals Increased Pyruvate Carboxylase Flux in an Insulin-Resistant Mouse Model
Philip Lee, Waifook Leong, Trish Tan, Miangkee Lim, Weiping Han, George Karoly Radda · 2012 · Hepatology
Assessment of Hepatic Mitochondrial Oxidation and Pyruvate Cycling in NAFLD by 13C Magnetic Resonance Spectroscopy
Kitt Falk Petersen, Douglas E. Befroy, Sylvie Dufour, Douglas L. Rothman, Gerald I. Shulman · 2016 · Cell Metabolism
Mitochondrial genome architecture in non‐alcoholic fatty liver disease
Silvia C. Sookoian, Diego Martin Flichman, Romina Scian, Cristian Rohr, Hernán Dopazo, Tomas Fernández Gianotti, Julio San Martino, Gustavo Osvaldo Castaño, Carlos Jose Pirola · 2016 · The Journal of Pathology
Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
Carlos Jose Pirola, Silvia C. Sookoian · 2018 · World Journal of Gastroenterology
Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology
Sara Della Torre · 2021 · Cells
Imbalanced insulin action in chronic over nutrition: Clinical harm, molecular mechanisms, and a way forward
Kevin Jon Williams, Xiangdong Wu · 2016 · Atherosclerosis
Mitochondrial heterogeneity in diseases
Long Chen, Mengnan Zhou, Hao Li, Delin Liu, Peng Liao, Zong Yao, Changqing Zhang, Weiguo Zou, Junjie Gao · 2023 · Signal Transduction and Targeted Therapy
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses
Beatrice Foglia, Marc Beltrà, Salvatore Sutti, Stefania Cannito · 2023 · International Journal of Molecular Sciences
Metabolic pathway analysis using stable isotopes in patients with cancer
Caroline Bartman, Brandon Faubert, Joshua D. Rabinowitz, Ralph J. DeBerardinis · 2023 · Nature reviews. Cancer
The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease
Erin K. Daugherity, Gabriel Balmus, Ahmed Al Saei, Elizabeth S. Moore, Delbert S. Abi Abdallah, Arlin B. Rogers, Robert S. Weiss, Kirk J. Maurer · 2012 · Cell Cycle
Orally Administered Baker’s Yeast β-Glucan Promotes Glucose and Lipid Homeostasis in the Livers of Obesity and Diabetes Model Mice
Yan Li Cao, Ying Sun, Siwei Zou, Mengxia Li, Xiaojuan Xu · 2017 · Journal of Agricultural and Food Chemistry
Mass spectrometry-based microassay of2H and13C plasma glucose labeling to quantify liver metabolic fluxes in vivo
Clinton M. Hasenour, Martha L. Wall, D. Emerson Ridley, Curtis C. Hughey, Freyja D. James, David H. Wasserman, Jamey D. Young · 2015 · American Journal of Physiology-Endocrinology and Metabolism
Tracing metabolic flux through time and space with isotope labeling experiments
Doug K. Allen, Jamey D. Young · 2019 · Current Opinion in Biotechnology
The mitochondrial pyruvate carrier mediates high fat diet-induced increases in hepatic TCA cycle capacity
Adam J. Rauckhorst, Lawrence R. Gray, Ryan D. Sheldon, Xiaorong Fu, Alvin D. Pewa, Charlotte R. Feddersen, Adam J. Dupuy, Katherine Nicole Gibson-Corley, James Eric Cox, Shawn C. Burgess et al. · 2017 · Molecular Metabolism
Inhibition of Pyruvate Dehydrogenase Kinase 2 Protects Against Hepatic Steatosis Through Modulation of Tricarboxylic Acid Cycle Anaplerosis and Ketogenesis
Younghoon Go, Ji Yun Jeong, Nam Ho Jeoung, Jae‐Han Jeon, Bo-Yoon Park, Hyeon‐Ji Kang, Chae‐Myeong Ha, Young‐Keun Choi, Sun Joo Lee, Hye Jin Ham et al. · 2016 · Diabetes
Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP
Romeo Papazyan, Zheng Sun, Yong Hoon Kim, Paul M. Titchenell, David A. Hill, Wenyun Lu, Manashree Damle, Min Wan, Yuxiang Zhang, Erika R. Briggs et al. · 2016 · Cell Metabolism
Metabolic alterations and vulnerabilities in hepatocellular carcinoma
Daniel Geoffrey Tenen, Li Chai, Justin L. Tan · 2020 · Gastroenterology report
The Roles of NRF2-Regulated Oxidative Stress and Mitochondrial Quality Control in Chronic Liver Diseases
Jeong-Su Park, Nodir Rustamov, Yoon‐Seok Roh · 2023 · Antioxidants
Developmental Programming of Nonalcoholic Fatty Liver Disease: The Effect of Early Life Nutrition on Susceptibility and Disease Severity in Later Life
Ming-Lan Li, C. Reynolds, S. Segovia, C. Gray, M. Vickers · 2015 · BioMed Research International
Dipeptidyl Peptidase-4 Inhibition Ameliorates Western Diet–Induced Hepatic Steatosis and Insulin Resistance Through Hepatic Lipid Remodeling and Modulation of Hepatic Mitochondrial Function
Annayya Rao Aroor, Javad Habibi, David A. Ford, Ravi Nistala, Guido Lastra, Camila Margarita Manrique, Merlow M. Dunham, Kaitlin D. Ford, John P. Thyfault, Elizabeth Jane Parks et al. · 2015 · Diabetes
Propionate increases hepatic pyruvate cycling and anaplerosis and alters mitochondrial metabolism
Perry, Rachel J., Borders, Candace B., Cline, Gary W., Zhang, Xian-Man, Alves, Tiago C., Petersen, Kitt Falk, Rothman, Douglas L., Kibbey, Richard G., Shulman, Gerald I. · 2016 · Journal of Biological Chemistry
Protective effect of metformin against palmitate-induced hepatic cell death
Yana Geng, Alejandra Hernández Villanueva, Asmaa Oun, Manon Buist‐Homan, Hans Blokzijl, Klaas Nico Faber, Amalia M. Dolga, Han J. Moshage · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition
Anuradha Krishnan, Tasduq Sheikh Abdullah, Taofic Mounajjed, Stella P. Hartono, Andrea L. McConico, Thomas White, Nathan K. LeBrasseur, Ian R. Lanza, Sreekumaran Nair, Gregory Gores et al. · 2017 · American Journal of Physiology-Gastrointestinal and Liver Physiology
Molecular Interactions between NAFLD and Xenobiotic Metabolism
Adviti Naik, Aleš Belič, Ulrich M. Zanger, Damjana Rozman · 2013 · Frontiers in Genetics
Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus
Yuliya Kupriyanova, Oana‐Patricia Zaharia, Pavel Bobrov, Yanislava Karusheva, Volker Burkart, Julia Szendroedi, Jonghee Hwang, Michael Roden, Michael Roden, Hadi Al‐Hasani et al. · 2020 · Journal of Hepatology
Increased gluconeogenesis in youth with newly diagnosed type 2 diabetes
Stephanie Therese Chung, Daniel S. Hsia, Shaji K. Chacko, Luisa M. Rodríguez, Morey W. Haymond · 2014 · Diabetologia
Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics
Silvia C. Sookoian, Carlos Jose Pirola · 2019 · Seminars in Liver Disease
An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease
Javier de las Heras, Luis Jose Aldamiz-Echevarria, Maria Luz Martínez‐Chantar, Teresa C. Delgado · 2016 · Expert Opinion on Drug Metabolism & Toxicology
Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats
Mariane Róvero Costa, Jéssica Leite Garcia, Carol Cristina Vágula de Almeida Silva, Artur Junio Togneri Ferron, Fabiane Valentini Francisqueti‐Ferron, Fabiana Kurokawa Hasimoto, Cristina Schmitt Gregolin, Dijon Henrique Salomé de Campos, Cléverton Roberto de Andrade, Ana Lúcia Anjos Ferreira et al. · 2019 · Antioxidants
Reduced mitophagy is an early feature of NAFLD and liver-specific PARKIN knockout hastens the onset of steatosis, inflammation and fibrosis
Ramya Undamatla, Olayemi G. Fagunloye, J. Chen, L. R. Edmunds, A. Murali, A. Scott Mills, Bin Xie, Martha M. Pangburn, IAN J. SIPULA, Gregory A. Gibson et al. · 2023 · Scientific Reports
Contribution of mitochondria and endoplasmic reticulum dysfunction in insulin resistance: Distinct or interrelated roles?
Jennifer Rieusset · 2015 · Diabetes & Metabolism
Berberine ameliorates fatty acid-induced oxidative stress in human hepatoma cells
Yixuan Sun, Xinlu Yuan, Feifei Zhang, Yamei Han, Xinxia Chang, Xi Xu, Yu Li, Xin Gao · 2017 · Scientific Reports
Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
Francesco Bifari, Roberto Manfrini, Michele Dei, Cesare Berra, Matteo Siano, Massimo Giovanni Zuin, Rita Clara Paroni, Franco B. Folli · 2018 · Pharmacological Research
A Narrative Review on the Role of AMPK on De Novo Lipogenesis in Non-Alcoholic Fatty Liver Disease: Evidence from Human Studies
Christian von Loeffelholz, Sina Maren Coldewey, Andreas L. Birkenfeld · 2021 · Cells
Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet
Naoki Tanaka, Shogo Takahashi, Zhong‐Ze Fang, Tsutomu Matsubara, Kristopher W. Krausz, Aijuan Qu, Frank J. Gonzalez · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Quantitative analysis of the murine lipid droplet-associated proteome during diet-induced hepatic steatosis
Khan, Salmaan Ahmed, Wollaston-Hayden, Edith E., Markowski, Todd W., Higgins, LeeAnn, Mashek, Douglas G. · 2015 · Journal of Lipid Research
SGLT2 Inhibition for Cardiovascular Diseases, Chronic Kidney Disease, and NAFLD
Moein Ala · 2021 · Endocrinology
Cuproptosis to Cuproptosis‐Like: Therapeutic Strategies for Bacterial Infection
Wenqi Wang, Hengshuo Gui, Xiaolong Wei, Huiyu Liu, Xianwen Wang · 2025 · Advanced Materials
Dynamic Acetylation of Phosphoenolpyruvate Carboxykinase Toggles Enzyme Activity between Gluconeogenic and Anaplerotic Reactions
Pedro Latorre‐Muro, Josue Baeza, Eric A. Armstrong, Ramón Hurtado‐Guerrero, Francisco Corzana, Lindsay E. Wu, David A. Sinclair, Pascual López‐Buesa, José Alberto Carrodeguas, John M. Denu · 2018 · Molecular Cell
SIRT4 and Its Roles in Energy and Redox Metabolism in Health, Disease and During Exercise
Yumei Han, Shi Zhou, Sonja Coetzee, Anping Chen · 2019 · Frontiers in Physiology
Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis
Marija Branković, Igor Jovanović, Marija Dukić, Tijana Radonjić, Svetlana Oprić, Slobodan Klašnja, Marija D. Zdravkovic · 2022 · International Journal of Molecular Sciences
Increased hepatic gluconeogenesis and type 2 diabetes mellitus
Emma Barroso, Javier Jurado-Aguilar, Walter Wahli, Xavier Palomer, Manuel Vázquez‐Carrera · 2024 · Trends in Endocrinology and Metabolism
Insulin Regulates Hepatic Triglyceride Secretion and Lipid Content via Signaling in the Brain
Thomas Scherer, Claudia Lindtner, James O’Hare, Martina Theresa Hackl, Elizabeth Zieliński, Angelika Freudenthaler, Sabina M. Baumgartner-Parzer, Klaus Tödter, Jöerg Heeren, Martin Krššák et al. · 2016 · Diabetes
Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis
Srilaxmi Kalavalapalli, Fernando Bril, Jeremy P. Koelmel, Kaitlyn I. Abdo, Joy Guingab, P. Megan Andrews, Wenyi Li, Dhanya Jose, Richard A. Yost, Reginald F. Frye et al. · 2018 · American Journal of Physiology-Endocrinology and Metabolism
Controlled-release mitochondrial protonophore (CRMP) reverses dyslipidemia and hepatic steatosis in dysmetabolic nonhuman primates
Leigh Goedeke, Liang Peng, Valle Montalvo-Romeral, Gina M. Butrico, Sylvie Dufour, Xian‐Man Zhang, Rachel J. Perry, Gary W. Cline, Paul Kievit, Keefe Chng et al. · 2019 · Science Translational Medicine
Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease
Peter Russell Baker, Jacob E. Friedman · 2018 · Journal of Clinical Investigation
The Role of Mitochondrial Adaptation and Metabolic Flexibility in the Pathophysiology of Obesity and Insulin Resistance: an Updated Overview
Dimitrios Tsilingiris, Evangelia Tzeravini, Chrysi C. Koliaki, Μaria Dalamaga, Alexander D. Kokkinos · 2021 · Current Obesity Reports
Mitochondria- and NOX4-dependent antioxidant defense mitigates progression to nonalcoholic steatohepatitis in obesity
Spencer Greatorex, Supreet Kaur, Chrysovalantou E. Xirouchaki, Pei K. Goh, F. Wiede, A. Genders, M. Tran, Yaoyao Jia, Arthe Raajendiran, W. Brown et al. · 2023 · Journal of Clinical Investigation
Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA)
Rachel J. Perry, Liang Peng, Gary W. Cline, Gina M. Butrico, Yongliang Wang, Xian‐Man Zhang, Douglas L. Rothman, Kitt Falk Petersen, Gerald I. Shulman · 2017 · Nature Communications
Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease
Chris E. Shannon, Mukundan Ragavan, Juan Pablo Palavicini, Marcel J. Fourcaudot, Terry M. Bakewell, Ivan Valdez, Iriscilla Ayala, Eunsook S. Jin, Muniswamy Madesh, Xianlin Han et al. · 2020 · Molecular Metabolism
Loss of metabolic flexibility as a result of overexpression of pyruvate dehydrogenase kinases in muscle, liver and the immune system: Therapeutic targets in metabolic diseases
Jae‐Han Jeon, Themis Thoudam, Eun Jung Choi, Min‐Ji Kim, Robert A. Harris, In‐Kyu Lee · 2020 · Journal of Diabetes Investigation
Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non‐alcoholic steatohepatitis
Sara Guerra, Gabriele Mocciaro, Amalia Gastaldelli · 2021 · European Journal of Clinical Investigation
From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis
J. Bernadette Moore · 2019 · Proceedings of The Nutrition Society
Nutrition and Nonalcoholic Fatty Liver Disease
Manu V. Chakravarthy, Thomas K. Waddell, Rajarshi Banerjee, Nicola D. Guess · 2019 · Gastroenterology Clinics of North America
Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms
Ashok Mandala, R. Janssen, Sirish K. Palle, K. Short, J. Friedman · 2020 · Nutrients
β-Hydroxybutyrate is reduced in humans with obesity-related NAFLD and displays a dose-dependent effect on skeletal muscle mitochondrial respiration in vitro
Jacob T. Mey, Melissa Lynn Erickson, Christopher L. Axelrod, William T. King, Chris A. Flask, Arthur J. McCullough, John P. Kirwan · 2020 · American Journal of Physiology-Endocrinology and Metabolism
The role of hepatic lipid composition in obesity‐related metabolic disease
Scott A. Willis, Stephen Bawden, Sundus Malaikah, Jack Alistair Sargeant, David J. Stensel, Guruprasad Padur Aithal, James A. King · 2021 · Liver International
Reprogramming of Hepatic Metabolism and Microenvironment in Nonalcoholic Steatohepatitis
Liangyou Rui, Jiandie D. Lin · 2022 · Annual Review of Nutrition
High Protein Diet and Metabolic Plasticity in Non-Alcoholic Fatty Liver Disease: Myths and Truths
Francesco De Chiara, Cynthia Ureta Checcllo, Javier Ramón‐Azcón · 2019 · Nutrients
Discordant hepatic fatty acid oxidation and triglyceride hydrolysis leads to liver disease
Ebru S. Selen Alpergin, Joseph Choi, Michael J. Wolfgang · 2021 · JCI Insight
Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases
Bedair Dewidar, Lucia Mastrototaro, Cornelia Englisch, Claudia Ress, Cesare Granata, Elisabeth Rohbeck, Dominik Hans Pesta, Geronimo Heilmann, Martin F. Wolkersdorfer, Iréne Esposito et al. · 2023 · EBioMedicine
Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans
Manoj Amrutkar, Matthias Kern, Esther Nuñez‐Durán, Marcus Ståhlman, Emmelie Cansby, Urszula Chursa, Elin Stenfeldt, Jan Borén, Matthias Blüher, Margit Mahlapuu · 2015 · Diabetologia
Translational approaches: from fatty liver to non-alcoholic steatohepatitis.
Natalia Rosso, Norberto Carlos Chávez-Tapia, Claudio Tiribelli, Stefano Bellentani · 2014 · PubMed Central
Endoplasmic reticulum-mitochondria calcium signaling in hepatic metabolic diseases
Jennifer Rieusset · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
eNOS deletion impairs mitochondrial quality control and exacerbates Western diet-induced NASH
Ryan D. Sheldon, Grace Margaret-Eleanor Meers, E. Matthew Morris, Melissa A. Linden, Rory P. Cunningham, Jamal A. Ibdah, John P. Thyfault, M. Harold Laughlin, R. Scott Rector · 2019 · American Journal of Physiology-Endocrinology and Metabolism
ABCB10 exports mitochondrial biliverdin, driving metabolic maladaptation in obesity
Michaël Shum, C.A. Shintre, Thorsten Althoff, Vincent Gutierrez, Mayuko Segawa, Alexandra D. Saxberg, Melissa Martinez, R.J. Adamson, Margaret R. Young, Belinda Faust et al. · 2021 · Science Translational Medicine
Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice
Yufang Ding, Karin Yanagi, Fang Yang, Evelyn S. Callaway, Clint Cheng, Martha E. Hensel, Rani Menon, Robert Christopher Alaniz, Kyongbum Lee, Arul Jayaraman · 2023 · eLife
Gluconeogenesis Flux in Metabolic Disease
Ankit M. Shah, Fredric Edward Wondisford · 2023 · Annual Review of Nutrition
The association between different insulin resistance surrogates and all-cause mortality and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease
Xin Gao, Tianyi Chen, Feilong Zhou, Yanmei Sun, Jiaqi Zhang, Xinhao Li, Weijie Zhao, Yunxin Li, Yanlong Shi, Kaiyi Niu et al. · 2025 · Cardiovascular Diabetology
Increased Anaplerosis, TCA Cycling, and Oxidative Phosphorylation in the Liver of Dairy Cows with Intensive Body Fat Mobilization during Early Lactation
C.T. Schäff, Sabina Börner, Sandra Hacke, Ulrike Kautzsch, Dirk Albrecht, Harald Michael Hammon, Monika Röntgen, Björn Kuhla · 2012 · Journal of Proteome Research
Effects of Diets Differing in Composition of 18-C Fatty Acids on Adipose Tissue Thermogenic Gene Expression in Mice Fed High-Fat Diets
Sunhye Shin, Kolapo Matthew Ajuwon · 2018 · Nutrients
The mitochondrial fission protein Drp1 in liver is required to mitigate NASH and prevents the activation of the mitochondrial ISR
Janos Steffen, Jennifer Ngo, Sheng-Ping Wang, Kevin Williams, Henning Fritz Kramer, George Ho, Carlos J. Rodríguez, Krishna Yekkala, Chidozie J. Amuzie, Russell Bialecki et al. · 2022 · Molecular Metabolism
Approach to assessing determinants of glucose homeostasis in the conscious mouse
Curtis C. Hughey, David H. Wasserman, Robert S. Lee, Louise Lantier · 2014 · Mammalian Genome